Found's published rates bundle compounded medication and care, but the every-4-weeks billing cycle, insurance copays, and unstated lab and shipping fees create cost uncertainty. This breakdown shows what's included, what's separate, and how the annual math compares to transparent alternatives.

Found bundles compounded semaglutide or tirzepatide into its monthly membership price, but branded GLP-1 medications and insurance-track copays cost extra. This guide breaks down what's included, what's billed separately, and what you actually pay over 12 months.

Found's advertised rates are prepaid annual commitments, not promotional first-month prices. The $169 semaglutide figure requires $2,028 upfront; the month-to-month rate is $289. We show the true recurring cost over twelve months.

Found offers two pricing models—insurance-supported plans and cash-pay subscriptions—with rates ranging from a 12-month prepaid equivalent of $99/month to $359/month billed monthly. We break down each track's real recurring costs, medication coverage, and what the insurance option actually covers.

Found offers 12-month prepaid plans and an insurance track that can serve long-term maintenance well. Whether it beats cash-pay alternatives depends on your coverage and commitment horizon. We compare Found's maintenance fit against PlexusDx cash programs.

Found charges $289/month for compounded semaglutide and $359/month for tirzepatide on month-to-month cash plans. Their insurance track and 24/7 care team app deliver value for committed users, but PlexusDx costs $100–$70/month less on comparable plans.

Found offers standard-dose GLP-1s with optional insurance billing and 12-month prepaid plans; Remedy publishes only a microdose option at $189/month. We compare structures, pricing, and fit across both programs plus PlexusDx alternatives.